Table 2 Sequencing quality and mapping rate in each sample
Sample | Raw data | Clean data | Q30 | GC content | Total mapping rate | Uniquely mapped rate |
|---|---|---|---|---|---|---|
P_cancer_1 | 14.86G | 13.21G | 93.19% | 47.81% | 96.87% | 89.85% |
P_cancer_2 | 15.57G | 13.59G | 92.82% | 46.71% | 96.72% | 90.48% |
P_cancer_3 | 16.73G | 14.95G | 93.26% | 47.03% | 97.11% | 91.29% |
P_normal_1 | 15.75G | 13.68G | 92.58% | 46.51% | 97.17% | 92.56% |
P_normal_2 | 17.41G | 15.32G | 93.02% | 46.35% | 97.24% | 92.31% |
P_normal_3 | 15.08G | 12.90G | 93.56% | 47.58% | 97.38% | 92.17% |
S_cancer_1 | 17.60G | 15.67G | 93.73% | 47.40% | 97.45% | 90.80% |
S_cancer_2 | 15.38G | 13.56G | 93.80% | 47.46% | 97.12% | 90.55% |
S_cancer_3 | 15.26G | 13.54G | 93.79% | 47.83% | 97.06% | 90.39% |
S_normal_1 | 16.17G | 14.27G | 93.85% | 46.58% | 97.64% | 92.35% |
S_normal_2 | 16.39G | 14.40G | 93.91% | 47.44% | 97.45% | 90.99% |
S_normal_3 | 16.84G | 14.96G | 93.92% | 48.23% | 97.59% | 90.70% |